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SUMMARY 
 
Respiratory chain dysfunction plays an important role in human disease and aging. It is now 
well established that the individual respiratory complexes can be organized into 
supercomplexes, and structures for these macromolecular assemblies, determined by electron 
cryo-microscopy, have been described recently. Nevertheless, the reason why supercomplexes 
exist remains an enigma. The widely-held view that they enhance catalysis by channeling 
substrates is challenged by both structural and biophysical information. Here, we evaluate and 
discuss data and hypotheses on the structures, roles and assembly of respiratory-chain 
supercomplexes, and propose a future research agenda to address unanswered questions. 
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INTRODUCTION  
The structure, function and organization of the respiratory chain have been under investigation 
since Otto Warburg discovered Atmungsferment, the enzymatic basis for cellular respiration 
(Warburg, 1928). Thirty years later, progress in understanding how the mitochondrial 
respiratory chain drives ATP synthesis culminated in Peter Mitchell’s chemiosmotic 
hypothesis (Ernster and Schatz, 1981; Mitchell, 1961). Since then, molecular-level knowledge 
of the structures and mechanisms of the enzymes that comprise the respiratory chain and 
catalyze oxidative phosphorylation has exploded (Nicholls and Ferguson, 2013). Three proton-
translocating complexes, complex I (CI, NADH:ubiquinone oxidoreductase), complex III 
(CIII, ubiquinol-cytochrome c oxidoreductase) and complex IV (CIV, cytochrome c oxidase), 
connected by the mobile electron carriers ubiquinone (Q, ubiquinone-10 in humans) and 
cytochrome c (cyt c), catalyze electron transfer from NADH to O2. Many other pathways also 
contain enzymes that reduce ubiquinone to ubiquinol and so feed electrons into the respiratory 
chain. Proton translocation by CI, CIII and CIV generates a proton-motive force across the 
inner membrane that is used by F1Fo-ATP synthase to synthesize ATP. Consistent with the 
central role of oxidative phosphorylation in cellular energy metabolism, deficiencies in the 
enzymes that catalyze it are important contributors to human disease, both to rare inherited 
conditions and common age-associated diseases (Picard et al., 2016). 
 The organization of the mitochondrial respiratory complexes is commonly discussed in 
terms of two extreme models, the ‘fluid state’ and ‘solid state’ models. In the solid state model 
the complexes that catalyze individual reactions associate into single units capable of 
catalyzing whole reaction pathways (Keilin and Hartree, 1947). These solid-state devices 
contain Q and cyt c to transfer electrons along pre-defined, enclosed pathways between their 
component complexes, and do not exchange them with the outside. In contrast, in the fluid 
model individual complexes diffuse freely in the membrane, and Q and cyt c move randomly 
and without restraint between them (Hackenbrock et al., 1986). The fluid model was generally 
accepted until the invention of blue native polyacrylamide gel electrophoresis (BN-PAGE). By 
preserving interactions between the complexes, this technique enabled the separation and 
visualization of the multi-enzyme assemblies now known as supercomplexes (Schägger and 
Pfeiffer, 2000). Supercomplexes were criticized initially as artifacts of mild detergent 
solubilization, but their existence was then supported by experiments using a variety of non-
ionic detergents, and using separation by ultracentrifugation on sucrose density gradients 
(Acín-Pérez et al., 2008; Dudkina et al., 2005). Subsequently, they were observed in the 
absence of detergent in isolated cristae membranes, providing evidence of their existence in 
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situ (Davies et al., 2011). Supercomplexes have now been observed in diverse clades of 
organisms, including mammals (Schägger and Pfeiffer, 2000; 2001), plants (Eubel et al., 
2003), yeast (Schägger and Pfeiffer, 2000), and some bacteria such as Paracoccus denitrificans 
(Stroh et al., 2004), a relative of the protomitochondrion. However, they are not universal. For 
example, Escherichia coli contains patches of identical complexes grouped together in 
different parts of its cell membrane (Llorente-Garcia et al., 2014). In mitochondria from 
mammalian tissues, BN-PAGE has revealed supercomplexes of varying stoichiometry 
including CI/CIII2/CIV1-4, CI/CIII2 and CIII2/CIV1-2, and it has been estimated that 85-100% of 
CI and 55-65% of CIII, but only 15-25% of CIV, are found in supercomplexes (Greggio et al., 
2016; Schägger and Pfeiffer, 2001). Respirasomes are supercomplexes that contain CI, CIII 
and CIV and are capable of NADH:O2 oxidoreduction in vitro (CI/CIII2/CIV has been the most 
extensively studied). In organisms such as Saccharomyces cerevisiae, which do not express CI, 
only simpler superassemblies of CIII and CIV are present (III2/IV and III2/IV2) (Heinemeyer et 
al., 2007; Mileykovskaya et al., 2012; Schägger and Pfeiffer, 2000). 
 Here, we discuss how and why respiratory complexes are organized into supercomplex 
assemblies. Supercomplexes are now widely accepted by the scientific community, but the 
reason(s) for their existence, and whether they confer any functional or structural advantage, or 
contribute to the pathophysiology of human disease, remain under debate. We explore 
knowledge of their structures, evidence for specific factors that promote them, functional data 
on their proposed roles in enhancing catalytic efficiency or decreasing oxidative stress, and 
data relevant to the interplay between supercomplex formation and the topology, packing and 
stability of inner membrane structures. 
 
Structures of mammalian supercomplex assemblies  
Recent developments in single-particle electron cryo-microscopy (cryo-EM) (Fernandez-Leiro 
and Scheres, 2016) have led to a proliferation of relatively high resolution structural models of 
the mammalian respirasome (Gu et al., 2016; Letts et al., 2016; Sousa et al., 2016; Wu et al., 
2016). Figures 1A and 1B show the structure of the respirasome from porcine heart 
mitochondria determined at 5.4 Å resolution (Gu et al., 2016). In the architecture shown, 
representative of all the mammalian structures described so far (Althoff et al., 2011; Dudkina 
et al., 2011; Gu et al., 2016; Letts et al., 2016; Sousa et al., 2016; Wu et al., 2016), the 
membrane arm of CI curves around the CIII dimer with CIV positioned on the toe of CI, 
interacting with both CI and CIII. 
 The structure of the porcine respirasome was published back-to-back with three 
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structures from ovine heart mitochondria (Letts et al., 2016), which arose from using cryo-EM 
particle classification to distinguish molecules with different compositions or conformations 
(Scheres, 2016). Two structures are respirasome structures, and one lacks CIV. Figure 1C 
compares the three respirasome structures (Gu et al., 2016; Letts et al., 2016) and highlights the 
conserved arrangement of CI and CIII but the varying location of CIV. From the porcine 
structure, to the ‘tight’ ovine respirasome, to the ‘loose’ ovine respirasome, and finally to the 
ovine structure lacking CIV entirely, CIV rolls around the tip of CI, gradually dissociating 
from CIII, and finally from the respirasome completely. Further structural variation has since 
been observed in data on the bovine respirasome, in which one class shows the CIII dimer 
rotated by 25º relative to CI (breaking specific interactions between them) (Sousa et al., 2016), 
and in further analyses of the porcine complex (Wu et al., 2016). 
 Figure 1C may depict the respirasome in various stages of disassembly, following its 
extraction from the membrane. Alternatively, respirasomes in the membrane may vary in 
structure, or be constantly dissociating, reforming and reorganizing. Tomographic structures of 
the complexes in situ (Davies et al., 2011; Wan and Briggs, 2016) and single molecule imaging 
(Wilkens et al., 2013) will be required to distinguish these alternatives. Importantly, the 
integrities of supercomplex assemblies in BN-PAGE are well known to depend on the type and 
concentration of detergent used to solubilize them out of the membrane; the solubilization 
condition must be strong enough to release the complexes, but mild enough to preserve the 
interactions between them. Furthermore, cryo-EM grid formation exposes samples to a large 
air-water interface and may destabilize or degrade weakly bound assemblies such as 
supercomplexes. Cryo-EM analyses themselves may provide additional bias by excluding large 
numbers of the particles imaged from the analysis. Whereas Sazanov and coworkers only 
discarded 22% of their imaged particles (Letts et al., 2016), Wang and coworkers discarded 62-
64% (Gu et al., 2016; Wu et al., 2016) and Kühlbrandt and coworkers 75% (Sousa et al., 
2016). Different approaches to particle classification and selection affect these values, but the 
substantial inhomogeneity present in all the preparations imaged deserves consideration. 
 The recent structures (Gu et al., 2016; Letts et al., 2016; Wu et al., 2016) have provided 
new information about specific interactions between subunits of the different complexes. 
Complexes I and III interact predominantly in two regions: NDUFA11 and NDUFB4 on CI 
interact with UQCRQ on CIII, and NDUFB9 and NDUFB4 interact with UQCRC1 and 
UQCRFS1 (the Rieske protein) (Letts et al., 2016; Wu et al., 2016). Notably, the contacts are 
dominated by the CI supernumerary (accessory) subunits, which are crucial for assembly and 
function of human CI (Stroud et al., 2016), rather than by the core subunits (Fiedorczuk et al., 
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2016; Zhu et al., 2016). Although it has been proposed that the supernumerary subunits have 
undergone selection during evolution to favor supercomplex-stabilizing interactions (Letts et 
al., 2016), an equally valid proposal is that selection has instead favored them forming cage-
like structures that protect the catalytically-active core subunits of the complexes from too 
close, restrictive interactions. The interactions that the less-tightly bound CIV forms with CI 
and CIII vary between the different respirasome structures (Letts et al., 2016; Wu et al., 2016), 
with a close interaction between CIV subunit COX7A and CIII subunit UQCR11 in the porcine 
structure that is progressively lost in the two ovine structures (Figure 1C). 
 
Relationship between supercomplexes and inner membrane architecture 
Mitochondria have a distinctive morphology due to being bounded by both an encasing outer 
membrane and an invaginated inner membrane that forms in-folded protrusions known as 
cristae. Cristae are pinched off at their base by the mitochondrial contact site and cristae 
organizing (MICOS) complex (Milenkovic and Larsson, 2015; Pfanner et al., 2014) separating 
the inner boundary membrane (which is juxtaposed to the outer membrane) from the cristae 
membrane (which projects into the matrix). Supercomplexes are highly enriched in the cristae 
membrane (Appelhans et al., 2012; Busch et al., 2013; Gilkerson et al., 2003; Vogel et al., 
2006; Wilkens et al., 2013). F1Fo-ATP synthase dimers define the membrane topology by 
organizing into ribbon-like structures on the highly curved tips of the cristae (Davies et al., 
2011; Strauss et al., 2008). In contrast, the respiratory complexes are present predominantly on 
the planar cristae surfaces (Davies et al., 2011; Vogel et al., 2006; Wilkens et al., 2013). 
Consistent with this, a striking feature of the respirasome is its disc-like structure (Gu et al., 
2016; Letts et al., 2016). Cristae remodelling (which disrupts the membrane topology) has been 
observed to disrupt the supercomplexes in the cristae (Cogliati et al., 2013) and an 
interdependent relationship between topology and supercomplex stability has probably arisen 
through their co-evolution. Finally, the dimerization of isolated CIV by interactions involving 
subunit COX6A (Tsukihara et al., 1996) has been used to suggest that respirasomes may form 
dimers and higher-order oligomers such as respiratory strings (Dudkina et al., 2010) through 
dimerization of their CIV monomers, since COX6A faces outside. However, when two 
supercomplex structures are aligned onto the CIV dimer structure the resulting supercomplex 
dimer is V-shaped, not planar (Letts et al., 2016). The larger supercomplex formed by 
arranging two CI and two CIV molecules around a common CIII dimer, as tentatively observed 
by Wu and coworkers (Wu et al., 2016) is more likely to remain consistent with the planar 
cristae membrane environment. 
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Importance of phospholipid interactions for supercomplex structure and function 
Cardiolipin is the signature phospholipid of mitochondria, present in high amounts in the inner 
mitochondrial membrane (Mileykovskaya and Dowhan, 2009; 2013) where it is generally 
considered to stabilize supercomplexes in both yeast and mammals (Figure 2). Budding yeast 
strains with defective cardiolipin synthesis contain unstable supercomplexes that have only 
been visualized using clear native-PAGE, a milder version of BN-PAGE (Pfeiffer et al., 2003; 
Zhang et al., 2005). In addition, supercomplexes between CIII and CIV can only be 
reconstituted in liposomes when cardiolipin is present (Bazán et al., 2013). In mammalian 
systems, fewer supercomplexes can be observed in mitochondria from patients with Barth 
syndrome (McKenzie et al., 2006) who carry an X-linked mutation in the taffazin protein that 
transfers acyl chains between lipids and is required for cardiolipin remodeling (Schlame and 
Greenberg, 2017). Furthermore, it has been proposed recently that, by sequestering cardiolipin, 
the supercomplexes protect it from phospholipases (Xu et al., 2016). Thus, in Barth syndrome, 
defective cardiolipin remodeling may lead to decreased supercomplex stability, then (in a 
vicious cycle) to further cardiolipin release and degradation, augmenting the original effect. 
 In supercomplex structures the complexes are only loosely associated with one another, 
with plenty of space to accommodate phospholipids between them. Although cardiolipin is 
considered to stabilize supercomplexes, phosphatidylethanolamine, another inner membrane 
phospholipid, has been reported to destabilize them (Böttinger et al., 2012). Thus, maintaining 
the correct balance of phospholipid species between the complexes may be important. A 
number of phospholipids were resolved in the structure of the porcine respirasome, but in 
positions that probably stabilize individual complexes, rather than interactions between them 
(Wu et al., 2016). Indeed, it is well established that cardiolipin is required for the stability of 
many membrane proteins, including the respiratory chain complexes (McKenzie et al., 2006; 
Mileykovskaya and Dowhan, 2009; 2013), making it difficult to distinguish its effects on 
individual complexes from its effects on supercomplexes as a whole.  
 
Are specific proteins required for supercomplex formation or stability? 
Three independent groups have reported that respiratory complex factors 1 and 2 (Rcf1 and 
Rcf2) are required for formation/stabilization of CIII/CIV supercomplexes in yeast (Chen et 
al., 2012; Strogolova et al., 2012; Vukotic et al., 2012), and similarly a mammalian ortholog of 
Rcf1, Hig2a, affects CIV-containing supercomplexes (Chen et al., 2012). However, Rcf1 and 
Rcf2 have also been reported to be required for CIV assembly (Vukotic et al., 2012), Higd1a 
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(another ortholog of Rcf1) has been shown to bind to mammalian CIV and increase its activity 
by causing structural changes around heme a (Hayashi et al., 2015), and knocking out Rcf1 and 
Rcf2 in yeast decreased CIV activity (Rydström Lundin et al., 2016). Therefore, the effects of 
these proteins on supercomplex formation/stabilization are probably indirect. Likewise, the 
cardiolipin-binding protein C11orf83, reported to stabilize CIII-containing supercomplexes 
(especially III2/IV in mammalian cells), is also necessary for both an early stage of CIII 
assembly and cristae maintenance (Desmurs et al., 2015). Another cardiolipin-binding factor, 
stomatin-like protein 2, reported to affect supercomplex formation/stabilization in T-cells, is 
also involved in compartmentalizing cardiolipin in the inner membrane (Mitsopoulos et al., 
2015). Finally, mice deficient in the co-chaperone MCJ/DnaJC15, which has known roles in 
protein transport and sensitivity to chemotherapeutic agents (Sinha et al., 2016), have been 
reported to have higher levels of supercomplexes in their mitochondria, and higher rates of 
respiration. Thus, MCJ/DnaJC15 has been proposed as a negative regulator of supercomplex 
formation/stability (Champagne et al., 2016; Hatle et al., 2013). However, rates of CI catalysis 
are increased in the deficient mice, and levels of monomeric CI are not appreciably decreased, 
suggesting the results are influenced by higher CI content and/or activity and that the effects of 
MCJ/DnaJC15 on supercomplex formation/stabilization may be indirect also. 
 No densities from any of these proteins have been identified in structural data (Gu et 
al., 2016; Letts et al., 2016; Wu et al., 2016). Although available cryo-EM density maps are not 
yet at high enough resolution to allow individual residues to be identified, and so have been 
modeled by docking in the pre-existing structures of each individual complex (Fiedorczuk et 
al., 2016; Iwata et al., 1998; Tsukihara et al., 1996; Vinothkumar et al., 2014; Zhu et al., 2016), 
all the protein densities observed are accounted for by the 80 subunits of CI, CIII and CIV. It 
cannot be excluded that additional features will be resolved at higher resolution, but it is to be 
expected that transmembrane helix-containing proteins with important stabilizing roles would 
already have been observed because such proteins are expected to be tightly and 
stoichiometrically bound between the complexes. Although no supercomplex assembly factors 
have been identified in structural data, the existence of such factors cannot be excluded 
because they would be expected to only associate transiently with the nascent supercomplex.  
 In contrast to the proteins described above, the COX7A2-like protein COX7A2L (a.k.a. 
supercomplex assembly factor 1 or SCAFI), was described as a specific factor required for the 
interaction between CIII and CIV and thus for formation/stabilization of the III2/IV and 
I/III2/IV (respirasome) supercomplexes (Ikeda et al., 2013; Lapuente-Brun et al., 2013). The 
report that C57BL/6 mice harbor a shorter allele of Cox7a2l, which leads to the expression of 
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an unstable COX7A2L protein and lack of CIV-containing supercomplexes (Lapuente-Brun et 
al., 2013), contrasted with previous observations of respirasomes in C57BL/6 mice 
(Milenkovic et al., 2013; Sterky et al., 2012). In a study directly comparing mouse strains 
expressing the short (C57BL/6J, C57BL/6N) and long isoforms of Cox7a2l (CD1, BALB/c), it 
was confirmed that the III2/IV supercomplex is dependent on the long isoform of COX7A2L 
(Mourier et al., 2014). However, fully assembled respirasomes and normal respiratory chain 
function were clearly observed in mice expressing both isoforms (Mourier et al., 2014). A 
mouse knockout for Cox7a2l created on the C57BL/6 background also showed the presence of 
CIV-containing supercomplexes, although their steady-state levels appeared lower (Ikeda et al., 
2013), and studies in human cell lines found respirasome formation to be independent of the 
presence of COX7A2L (Pérez-Pérez et al., 2016). Enríquez and coworkers subsequently 
proposed that respirasomes are present in the heart and skeletal muscle of mice expressing the 
short COX7A2L isoform, but absent from the liver and most other tissues (Cogliati et al., 
2016). However, other studies have observed respirasomes in the liver of mice expressing the 
short COX7A2L isoform (Jha et al., 2016; Mourier et al., 2014; Williams et al., 2016) (Table 
1). Therefore, COX7A2L is not essential for formation/stabilization of the respirasome. It 
clearly does assist in formation/stabilization of the III2/IV supercomplex (Pérez-Pérez et al., 
2016), which can only been observed in mice that harbor the long COX7A2L isoform, and not 
in the C57BL/6 strain (Table 1 and Figure 2).  
 Due to lack of additional attributable density for COX7A2L in recent cryoEM maps, 
and high sequence similarity between COX7A2L and tissue-specific isoforms of COX7A, it 
was speculated that COX7A2L may replace COX7A in supercomplexes, acting as a bridge 
between CIII and CIV and stabilizing the III2/IV interaction (Letts et al., 2016). Figure 1C 
shows how COX7A/COX7A2L moves relative to CIII subunit UQCR11 in the three 
respirasome structures described, consistent with the CIII/CIV interface being an inherently 
weak point of the respirasome and with COX7A/COX7A2L being a central feature of this 
interface. In mass spectrometric analyses of digitonin-solubilized mitochondria from CD1 mice 
(that express the long COX7A2L isoform), COX7A was present almost exclusively in 
monomeric/dimeric CIV, whereas COX7A2L was present in III2/IV supercomplexes and 
respirasomes (Cogliati et al., 2016). We have previously shown that COX7A2L is a CIII-
associated protein (Pérez-Pérez et al., 2016), and Enríquez and coworkers also detected 
COX7A2L bound to CIII in C57BL/6 mice (Cogliati et al., 2016). Together, these observations 
suggest that the homologous region of COX7A2L substitutes for COX7A and interacts with 
CIV, and that CIII donates COX7A2L to form the III2/IV interface. Figure 3 proposes how the 
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long COX7A2L isoform displaces COX7A from CIV to form a tight III2/IV interface either in 
III2/IV-containing supercomplexes or respirasomes. It also suggests how respirasomes with 
only a weak III2/IV interface form in the absence of COX7A2L, through interactions solely 
with CI. Whether the variants of the respirasome structure shown in Figure 1C correspond to 
respirasomes with tight or weak III2/IV interfaces formed in these ways is not known. 
 Enríquez and coworkers used mutagenesis to identify residues in mouse COX7A2L that 
are important for the III2/IV interaction (Cogliati et al., 2016). They found that His73, within 
the COX7A homologous region, is critical for the interaction between COX7A2L and CIV. 
The microdeletion in the short COX7A2L isoform removes two amino acid residues adjacent 
to His73, which may explain its inability to promote the III2/IV interaction (Cogliati et al., 
2016). Intriguingly, His73 in COX7A2L and the corresponding histidines in COX7A1 and 
COX7A2 are all replaced by tyrosines in humans, further underlining the importance of 
conserving this residue. Moreover, the roles of COX7A1/A2 and COX6A1/A2, which are 
subunits of CIV with tissue specific expression, were investigated and it was proposed that 
COX7A1 and COX6A2 promote CIV dimerization (Cogliati et al., 2016). 
Interpreting supercomplex structures to learn about their functions 
It is not easy to derive information about the catalytic mechanisms of redox enzymes from their 
structures. For the respirasome it is striking that the same structural information has repeatedly 
been interpreted in two very different ways, to either support or dismiss substrate-channeling 
hypotheses. In 2011, Kühlbrandt and coworkers (Althoff et al., 2011) proposed that 
supercomplexes are solid-state devices that construct pathways for the enclosed exchange of 
ubiquinone/ubiquinol between CI and CIII, and for cyt c between CIII and CIV, and they 
repeated this assertion recently (Sousa et al., 2016). In contrast, also in 2011, Boekema and 
coworkers (Dudkina et al., 2011) noted that proximity of the active sites may help to decrease 
the time required for random diffusion between them, but considered the concept of 
constructing the supercomplex to decrease the distances questionable. In 2016, Sazanov and 
coworkers noted the distinct lack of any substrate channels, or barriers to free diffusion, to 
connect the substrate-binding sites of CI, CIII and CIV in their structures (Letts et al., 2016). 
Figure 4A uses a structural perspective to consider the possibility that Q is channeled 
through the membrane, between CI and CIII. Ubiquinol exits CI at a peripheral location in the 
supercomplex (Baradaran et al., 2013; Zhu et al., 2016) and no confining structure exists to 
guide it to the Qo site of the closest CIII monomer, on the opposite face of the membrane. 
Thus, it is free to diffuse in and out of the region between the two binding sites and to 
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exchange with the greater membrane environment — the lack of confining structure is 
inconsistent with substrate channeling. The structures of enzymes that really do channel 
substrates (typically highly reactive or toxic substrates) exhibit enclosed channels between the 
sites, which allow no escape or exchange (Weeks et al., 2006). Similarly, Figure 4B considers 
the possibility of cyt c channeling between CIII and CIV. Cyt c is located in the intermembrane 
space and diffuses in a thin volume along the inner membrane surface (Gupte and 
Hackenbrock, 1988). In Figure 4B, two cyt c molecules have been added to indicate their 
relative size and approximate binding sites on CIII (Lange and Hunte, 2002). Reduced cyt c 
interacts with a negatively-charged patch on CIV (Shimada et al., 2016; Tsukihara et al., 1996). 
Again, no confining structures exist to contain the cyt c molecules between the two specific 
sites and prevent them diffusing away. Therefore, structural data do not support substrate 
channeling. The close proximities of the active sites within the supercomplex may increase the 
probability of a substrate re-reacting within the same respirasome, but the substrates are 
unconstrained and free to move in any direction, either within or between respirasomes. 
Indeed, the close active site proximities result naturally from the high packing density in the 
inner membrane, independently of the specific arrangements of the complexes in 
supercomplexes. 
 The orientation of the CIII dimer in the respirasome (one monomer facing CI and one 
facing out) has recently led to speculation that the ‘inner’ monomer may dominate catalysis 
because its ubiquinol-oxidizing Qo site is closest to the ubiquinol-producing site of CI (Sousa 
et al., 2016) and because the movement of its Rieske domain appears less hindered by CIV 
(Letts et al., 2016). The asymmetry imposed by the respirasome is not present in isolated CIII, 
in which both monomers are active (Sarewicz and Osyczka, 2015), so little data exists to 
address this hypothesis. Furthermore, despite decades of study and an extensive scientific 
literature, Yang and coworkers (Wu et al., 2016) used their structure to propose a new 
mechanism for CIII. Whereas ubiquinol is known to be oxidized at the Qo site on the inter-
membrane space side of the membrane in a ‘bifurcating’ electron transfer reaction that, by 
sending one of the two electrons across the membrane to ubiquinone bound at the Qi site, 
increases the number of protons transported across the membrane (Sarewicz and Osyczka, 
2015), Yang and coworkers proposed that ubiquinol is in fact oxidized at the Qi site, and that 
the two protons generated ‘might’ then be transported across the membrane (Wu et al., 2016). 
Their model is inconsistent with all extant data on the mechanism of CIII (Sarewicz and 
Osyczka, 2015) and with its known proton-pumping stoichiometry (Nicholls and Ferguson, 
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2013), and it fails to complete a basic Q cycle for proton-electron transfer across the membrane 
as embodied by Mitchell’s chemiosmotic theory (Mitchell, 1975). 
 
Supercomplexes do not channel substrates or partition the Q or cyt c pools 
Early work on distinguishing whether the Q pool in the inner mitochondrial membrane behaves 
as a single, freely-diffusing homogenous pool or whether Q molecules are sequestered into 
individual solid-state supercomplexes, has been reviewed in detail previously (Rich, 1984). 
Several lines of evidence led to a general consensus for a single, homogeneous pool that 
exchanges between all the membrane-bound complexes: i) calculations based on the diffusion 
coefficient of Q estimated that around 80 CIII dimers could be visited during a single CIII 
turnover during state 3 respiration; ii) predictions based on pool equations and comparison 
with experimental data provided evidence for a common substrate pool that could be reduced 
either by CI or CII (Kröger and Klingenberg, 1966; 1973); and iii) extraction of quinones 
followed by their reconstitution into membranes (which were also diluted with additional 
lipids) revealed a dependence on Q concentration consistent with a mobile Q pool in 
stoichiometric excess over the enzyme complexes (Schneider et al., 1982; 1980). 
 The solid-state model was subsequently revived by identification of supercomplex 
assemblies by BN-PAGE, and particularly by a report stating that isolated respirasomes 
(excised from BN-PAGE gels) that contain CI, CIII and CIV as well as co-purified Q and cyt c 
are able to catalyze electron transfer from NADH to O2 (Acín-Pérez et al., 2008). Indeed, the 
isolated respirasome can be considered a solid-state device (Q is trapped in its 
phospholipid/detergent micelle and cyt c remains associated) — but once it is placed in a 
membrane diffusion and exchange of Q and cyt c may occur. Data from flux control analyses 
have been taken to support the existence of independently-catalyzing respirasomes embedded 
in the membrane (Bianchi et al., 2004). In these analyses, a particular step in a pathway is 
inhibited and the effects on the isolated step and on the pathway compared. If the inhibition is 
identical, then the step has complete control over the pathway flux and its flux control 
coefficient (FCC) is 1. Lenaz and coworkers used rotenone and mucidin to obtain FCC values 
of 1 for both CI and CIII in the NADH oxidation pathway, suggesting they operate as a single 
entity (Bianchi et al., 2004). However, the analyses relied on large extrinsic concentrations of 
hydrophilic quinones and cyt c to assay the individual steps, whereas the pathway uses the Q 
and cyt c that exist in situ. Consequently, individual steps may behave differently in isolation 
and in the pathway, and high extrinsic quinone concentrations displace competitive inhibitors 
so the choice of inhibitor may affect the results. It has since been reported that two canonical 
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CI inhibitors, piericidin A and rotenone, give very different FCC values (Blaza et al., 2014): in 
different experimental systems, the values measured for piericidin A were between 0.2 and 0.7, 
but those for rotenone between 1.7 and 3.9. The sum of all the FCC values for a pathway 
should equal 1, so values greater than 1 are not biologically meaningful (Fell, 1992), and the 
inhibitor dependence of the FCC values further questions the reliability of this approach. 
 In 2013, Enríquez and coworkers re-proposed the solid model of the respiratory chain 
by reporting that supercomplexes define dedicated Q and cyt c pools (Lapuente-Brun et al., 
2013). According to their model, neither Q nor cyt c form homogeneous pools, but instead 
each supercomplex contains its own tiny pools that do not exchange with the tiny pools in 
other supercomplexes. However, the data used to support this model are also consistent with 
other explanations that are dependent on neither the involvement of supercomplexes nor 
partitioning of the Q and cyt c pools. First, in mouse fibroblasts with a constitutively low CIII 
expression, the activity of CI was moderately decreased but the activity of CII slightly 
increased. Both observations were explained subsequently by the same authors by increased 
production of reactive oxygen species (ROS) leading to CI disassembly (Diaz et al., 2012) and 
to activation of CII by phosphorylation (Acín-Pérez et al., 2014). Second, in the same 
fibroblasts the rate of CI+CIII catalysis was unchanged but the rate of CII+CIII catalysis was 
decreased, and this interesting discrepancy led to the proposal that CI sequesters CIII into 
supercomplexes, leaving little CIII available for CII catalysis. However, an alternate and 
perhaps simpler explanation is that CI+CIII catalysis is limited by one or more factors external 
to the respiratory chain (e.g. the upstream production of NADH) and therefore not affected by 
decreased CI or CIII activity, whereas CII+CIII catalysis is limited by CIII. Third, the authors 
observed that in CD1 mice (long Cox7a2l isoform) the sum of the rates of respiration on 
NADH- and succinate-linked substrates was equivalent to the rate in the presence of both, 
whereas in C57BL/6 mice (short Cox7a2l isoform) this was not the case. They ascribed the 
additive behavior in CD1 mice to the presence of separate Q pools for each pathway. However, 
an alternate explanation could well be that CIII+CIV catalysis is quick enough to ‘keep up’ 
with the increased rate of ubiquinone reduction. 
 In 2014, submitochondrial particles and membrane preparations from Bos taurus heart 
mitochondria were used to test directly whether partitioning of the Q and cyt c pools occur 
(Blaza et al., 2014). The preparations used contained a full complement of supercomplexes, 
with the CI and CII active sites exposed directly to added substrates. By using different 
amounts of cyt c to vary the CIII+CIV rate and thus alter the identity of the rate limiting steps 
for NADH and succinate oxidation, it was demonstrated how the same system, with the same 
 13 
supercomplex content, could exhibit both additive and non-additive kinetics, excluding this as 
an argument for Q pool partitioning (Figure 5A). Furthermore, the addition of NADH, 
succinate, or both reductants together (in the absence of O2), reduced essentially the same 
population of CIII, CIV and cyt c in every case (Figure 5B). These experiments did not reveal 
any additive effects and so also argue against partitioning of the Q pool. Only the spectroscopic 
time traces from the b-hemes in CIII varied significantly between the three conditions, but due 
to their low reduction potentials the b-hemes are incompletely reduced in all cases. Finally, the 
rate of NADH oxidation was compared with the rate of reverse electron transport, in which the 
proton-motive force from ATP hydrolysis is used to drive electron transport from succinate to 
NAD+, backwards through CI (Figure 5C). The rate of reverse electron transport, which 
requires CI and CII to share a common Q pool, was comparable to that of NADH oxidation. 
Using elegant heme spectroscopy in intact living cells, others have further demonstrated that 
cyt c in S. cerevisiae does not face major barriers to its free diffusion (Trouillard et al., 2011), 
and this is consistent with all the CIV present being catalytically active, rather than only the 
15-25% of it that is present in supercomplexes. 
 In our opinion, robust evidence for the partitioning of the Q and cyt c pools and for the 
channeling of either substrate is thus lacking. Instead, all functional and structural evidence is 
consistent with their free diffusion. Indeed, we contend that trapping a tiny pool of Q and cyt c 
within each supercomplex would be detrimental to respiratory chain function: it would 
preclude redox sensing by the pools and render the system less able to withstand individual 
complexes being dysfunctional. Notably, our conclusion does not support either the fluid or the 
solid-state model for respiratory chain organization. The original formulations of the two 
models linked function and structure tightly together, but this is now seen to be misleading: Q 
and cyt c diffuse between complexes or supercomplexes in any configuration. Recently, a 
‘plasticity model’ has been proposed as a hybrid model that encompasses pool partitioning but 
allows the pools to overflow to give the appearance of being one (Lenaz et al., 2016), and that 
borrows elements from both models to be consistent with all extant data (Enríquez, 2016; 
Moreno-Loshuertos and Enríquez, 2016). Whereas partitioning of the Q and cyt c pools is a 
problematic concept for the reasons discussed above, the plasticity model proposes that 
supercomplexes are dynamic entities that are constantly dissociating and reforming, and this 
latter interesting aspect is worthy of further investigation. 
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If not substrate channeling, what is the raison d’être of supercomplex formation? 
The existence of respiratory chain supercomplexes as structural entities is now widely accepted 
and it is natural to anticipate that, having evolved, they confer one or more functional 
advantages. Having ruled out substrate channeling, we now turn to alternative possibilities for 
why respiratory chain supercomplex formation is beneficial to the cell, namely: i) decreasing 
ROS production; ii) stabilizing or assisting in the assembly of the individual complexes; iii) 
regulation of respiratory chain activity; or iv) prevention of protein aggregation in the protein 
rich mitochondrial inner membrane.  
 i) CI and CIII are considered the main sites of ROS production by the respiratory chain 
(Murphy, 2009). Based on measurements of ROS production by isolated bovine heart 
mitochondria and by reconstituted liposomes containing CI and CIII either independently or in 
the I/III2 supercomplex, and solubilized with different detergents to either maintain or disrupt 
the supercomplexes, Genova and coworkers proposed that supercomplex formation decreases 
ROS production (Maranzana et al., 2013). Being made in the presence of respiratory-chain 
inhibitors, their experiments refer to ROS production by the CI flavin site (Kussmaul and Hirst, 
2006). However, access to the flavin site of CI is not hindered structurally by supercomplex 
formation, so it is difficult to rationalize the proposal. Furthermore, the ROS production rates 
measured were normalized using the rate of ubiquinone reduction by CI, a value that is easily 
modulated by changes in conditions and detergents, so lack of knowledge of the amount of CI 
present convolutes the interpretation. A correlation between ROS production and the level of 
CI present in supercomplexes has also been observed in neurons and astrocytes, cell types with 
very different bioenergetic properties (Lopez-Fabuel et al., 2016). For the CIII dimer, Sazanov 
and coworkers suggested that the asymmetry of the respirasome favors ubiquinone reduction at 
the Qi site closest to CIV, where locally decreased O2 concentrations may decrease ROS 
production. However, ROS formation by CIII is dominated by the QO site, not the Qi site 
(Sarewicz and Osyczka, 2015). Further work is thus required to investigate the interesting 
hypothesis that supercomplexes decrease ROS production. 
 ii) Mutations that cause defects in CIII or CIV may cause combined deficiencies in 
which CI is also affected (Acín-Pérez et al., 2004; Diaz et al., 2006). Because supercomplex 
formation/stability is often affected by the original defect, and defects in CI do not impact 
similarly on CIII and CIV, it has been proposed that CIII and CIV are required to stabilize CI 
through supercomplex formation (Acín-Pérez et al., 2004; Diaz et al., 2006; Schägger et al., 
2004). First, we note the effect is not universal: there are well-known examples of fully-
assembled CI being present when CIV is disrupted (Balsa et al., 2012). There are also many 
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human genetic conditions in which impaired CIV biogenesis leads to an isolated CIV 
deficiency (Diaz, 2010; Williams et al., 2004; Zhu et al., 1998), perhaps because in patients 
with low levels of CIV, the residual CIV is preferentially incorporated into respirasomes 
(Lazarou et al., 2009), and may be sufficient for their formation. Second, the effect can also be 
explained by a supercomplex-independent mechanism (Diaz et al., 2012; Guarás et al., 2016): 
when respiration is compromised (at CIII or CIV) reducing equivalents back-up into the 
NAD+/NADH pool and ROS production by CI increases (Kussmaul and Hirst, 2006); 
increased ROS is detrimental to CI stability, and loss of CI (and CIII or CIV) leads to lower 
supercomplex levels (Diaz et al., 2012). Evidence has since been presented that the increased 
ROS production arises from reverse electron transfer through CI (Guarás et al., 2016), with the 
same consequences. Thus, these combined respiratory-chain deficiencies present no 
unequivocal evidence for the interdependence of the complexes through supercomplex 
formation.  
Supercomplex formation in human cell lines has also been proposed to provide a 
scaffold for the completion of CI assembly (Moreno-Lastres et al., 2012). According to this 
model, the final section of the peripheral arm of CI (the pre-assembled NADH-oxidizing 
module) is only added once the nascent complex has been assembled into a supercomplex so 
that CI is not activated until the supercomplex is complete; this is consistent with CIII 
stabilizing partially-assembled CI in Ndufs4 knockout mice (Calvaruso et al., 2012). In 
contrast, recent proteomics studies that combined complexome profiling with BN-PAGE 
analyses to provide a detailed picture of CI assembly showed that the whole complex was 
assembled independently, before supercomplex formation and without a supercomplex scaffold 
(Guerrero-Castillo et al., 2016). Interestingly, NDUFA11 (a key subunit for the interaction of 
CI and CIII) and the pre-assembled NADH-oxidizing module are both added in the final stage 
of CI assembly. However, they are structurally independent in the complex, suggesting that 
they do not depend on one another for their incorporation. Therefore, the different results 
above probably reflect different balances between the independent rates at which CI assembly 
is completed and intercomplex associations are formed. 
 iii) The assembly and disassembly of supercomplexes are increasingly described as 
methods of regulating respiratory chain activity. For example, it was recently reported that 
exercise leads to increased supercomplex formation in human skeletal muscle (Greggio et al., 
2016). It has also been suggested (based on the existence of more than one Q pool) that the 
respiratory chain may adjust its supercomplexes to promote increased flux through CI or FAD-
linked dehydrogenases and assist in switching between carbohydrate and fatty-acid metabolism 
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(Lapuente-Brun et al., 2013). According to this model, activation of FAD-linked pathways 
causes over-reduction of the putative FAD-dedicated Q pool and upregulates ROS production 
by reverse electron transport through CI. The increased ROS production degrades CI and 
breaks down respirasomes to release CIII and the putative respirasome-associated Q-pool for 
FAD-linked respiration (Guarás et al., 2016). One weakness of this model is that it is internally 
inconsistent because, despite assuming the presence of separate Q pools, reverse electron 
transport between CI and CII requires Q to transfer between the two. Furthermore, a 
supercomplex-independent mechanism can achieve the same effect simply by increased ROS 
production leading to CI degradation. 
 Many varied studies will continue to observe changes to the levels of supercomplexes 
present in mitochondria, and correlate these to changes in metabolic conditions, the 
dysfunction, instability or absence of a respiratory complex, increased oxidative stress, or a 
change in morphology. However, it is important to recognize that correlation does not equate 
to causation, and to be cautious when making mechanistic assignments on the basis of indirect 
observations made on highly complex systems. 
 iv) The mitochondrial inner membrane is extremely protein-rich, with a phospholipid 
content of only around 30% (Fleischer et al., 1961). Therefore, supercomplexes may have been 
selected for because they prevent protein nucleation and aggregation (Blaza et al., 2014). The 
weak protein interactions that hold them together may prevent stronger deleterious interactions 
that would lead to loss of function, and the supernumerary subunits of the eukaryotic 
complexes may have evolved to promote these weak interactions. A well-known example of a 
similar strategy to prevent protein aggregation is in the lens of the eye, where densely packed 
protein molecules maintain the gel state by interacting only weakly with one another (Slingsby 
et al., 2013). Indeed, it is possible that supercomplexes form only in highly packed membranes 
due to either concentration-dependent association, or in response to a regulatory mechanism 
such as the expression of supercomplex assembly factors.  
 
CONCLUDING REMARKS AND FUTURE RESEARCH DIRECTIONS 
The organization of the respiratory chain is disrupted in a large number of human 
mitochondrial disorders caused by mutations in both mtDNA and nDNA (Wallace, 2010), such 
as Barth syndrome (McKenzie et al., 2006) and Leigh syndrome (McKenzie et al., 2007), as 
well as in a range of age-associated human diseases, such as heart failure (Rosca et al., 2011), 
and by the aging process itself (Frenzel et al., 2010; Gómez et al., 2009; Kauppila et al., 2016). 
A deterioration of respiratory chain supercomplex formation often forms part of the 
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biochemical disease phenotype, but the extent to which pathology and functional decline can 
be attributed to it is unclear. Recent advances in understanding the structures and organization 
of supercomplexes (Gu et al., 2016; Letts et al., 2016; Wu et al., 2016) now open new 
opportunities for testing their different proposed roles, particularly those centered on spatial 
organization or stability rather than catalysis. For example, it should now be possible to 
develop supercomplexes with enhanced interactions between the complexes, as well as to 
generate specific mutations that have no effect other than to disrupt supercomplex formation or 
stability. Biochemical studies on tightly-controlled systems in which supercomplex formation 
is the only variable are also required to study proposed properties such as the minimization of 
ROS production and the dependence on different phospholipids, in the absence of convoluting 
factors. Recent development of methods for reliable mitochondrial metabolomics (Chen et al., 
2016) may give insights into possible metabolite changes in response to supercomplex 
perturbations. Continuing advances in cryo-EM tomography, single-molecule labeling 
techniques and super-resolution light microscopy should be exploited for detailed and dynamic 
studies of respiratory chain organization in intact mitochondria and whole cells. Increased 
understanding in this area is clearly of great importance for the future, both for basic science 
and for understanding the roles of oxidative phosphorylation deficiencies in human disease and 
ageing. 
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FIGURE AND TABLE LEGENDS 
 
Figure 1. Structures of the respirasome. A) The arrangement of CI (orange), the CIII dimer 
(the monomers are shown in blue and cyan), and CIV (magenta) in the porcine respirasome, 
viewed along the membrane plane. B) The porcine respirasome viewed from the matrix. C) 
Comparison of the porcine and ovine respirasome structures. The structures were 
superimposed using the structure of the CIII dimer, to reveal the different relative positions of 
CI and CIV. CIV is shown as transparent over-lapping shapes (pink, porcine respirasome; 
magenta, tight ovine respirasome; blue, loose ovine respirasome). The transmembrane helix in 
CIV COX7A is highlighted to show how it moves relative to CIII UQCR11, which has been 
modeled in two slightly different positions. The figure was created using 5GPN.pdb (Gu et al., 
2016) (provided by the authors before release by the protein data bank), 5J4Z.pdb and 
5J7Y.pdb (Letts et al., 2016). 
 
 Figure 2. The presence of supercomplexes and respirasomes depends on COX7A2L and 
cardiolipin. A) The respiratory chain complexes of mouse strains harboring the long 
COX7A2L isoform (e.g. CD1 and BALB/c) are organized in respirasomes (I/III2/IV) and 
supercomplexes (I/III2 and III2/IV). B) Strains carrying the short COX7A2L isoform (e.g. 
C57BL/6 and DBA/2J) lack the III2/IV supercomplex. C) Deficiency of the mitochondrial 
signature phospholipid, cardiolipin, leads to destabilized supercomplex assemblies (light 
colors). 
 
 Figure 3. Proposal for how respirasomes form in the presence and absence of the long 
isoform of COX7A2L. A) Respirasome formation in the presence of the long isoform of 
COX7A2L. Top: the individual, fully-assembled complexes are CI, the CIII dimer and the CIV 
monomer. COX7A2L is weakly associated with CIII (it is not observed in the structure of CIII) 
and is proposed to interact with subunit UQCR11. COX7A is also shown as a CIV subunit. 
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Middle: a tight interface forms between CIII and CIV when COX7A2L replaces COX7A. 
Bottom: the III2/IV supercomplex associates with CI to form the respirasome. It is also 
possible that CIII and CIV both associate with CI before the III2/IV interface forms. B) 
Respirasome formation in the absence of the long isoform of COX7A2L. i) The individual, 
fully-assembled complexes are CI, the CIII dimer and the CIV monomer. COX7A is shown as 
a CIV subunit. ii) CIII and CIV both associate with CI but a tight interface is not formed 
between them. The III2/IV supercomplex is unstable. 
 
Figure 4. Ubiquinone and cyt c binding sites in the respirasome. A) The transmembrane 
helices in the respirasome, shown in the same orientation as Figure 1B. The exit from the CI 
ubiquinone-binding site is indicated, along with the positions of the two ubiquinol-binding 
sites in CIII. B) The respirasome viewed from the intermembrane space with two cyt c 
molecules shown to approximately indicate their binding sites on CIII, and the negatively-
charged patch on CIV where the reduced cyt c is reoxidized. The figure was created using 
5GPN.pdb for the porcine respirasome (Gu et al., 2016) (provided by the authors before release 
by the protein data bank). 
 
 Figure 5. Functional data that demonstrate there is only one Q pool in the inner 
mitochondrial membrane. A). Rates of O2 reduction by submitochondrial particles (SMPs) 
measured using NADH, succinate, or both substrates together. The sum of the individually-
measured rates is also shown. For SMPs prepared with additional cyt c, the rate of CIII+CIV 
catalysis is high so adding both substrates together increases the overall rate. For SMPs 
prepared without additional cyt c, the rate of CIII+CIV catalysis is low so the rate of O2 
reduction is constant, regardless of which substrate(s) are added. B). Reduction of the cyt c1 
heme in CIII and of cyt c upon addition of NADH, succinate, or both substrates together, 
followed spectroscopically. The relative extents of reduction are indicated for the ends of the 
traces shown and in all cases the hemes are close to fully reduced. C). The rates of different 
reactions measured in the same set of SMPs. Electrons can pass from CII to CI (in reverse 
electron transport) as fast as from CI to CIII+IV. Reverse electron transport from succinate to 
NAD+ requires ATP hydrolysis to overcome the potential difference. Data from Hirst and 
coworkers (Blaza et al., 2014). 
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Table 1. Overview of the literature on the supercomplex organization in C57BL/6 mouse 
strain harboring the short Cox7a2l isoform. +, present; -, absent; n.d., not determined. 
 
 
Study 
 
Mouse tissue 
(C57BL/6 
background) 
 
Supercomplex 
III2/IV1  
 
Respirasomes 
I/IIIn/IVn 
Lapuenete-Brun et al., 
2013 liver - - 
Ikeda et al., 2013 sk. muscle n.d. + 
Mourier et  al., 2014 heart / liver - + 
Jha et al, 2016 Liver - + 
Williams et al., 2016 liver / heart - + 
Perez-Perez et al., 
2016 heart - + 
Cogliati et al., 2016 
heart / sk. muscle - + 
liver / kidney / brain - - 
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